Search
for
Sort by
Research 361–390 of 1000+
- Maternal androgen excess significantly impairs sexual behavior in male and female mouse offspring: Perspective for a biological origin of sexual dysfunction in PCOS
- Workup and Management of Polycystic Ovary Syndrome
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Network-Based Drug Repositioning: Approaches, Resources, and Research Directions
- The Frequency of Metabolic Syndrome is Higher Among PCOS Brazilian Women With Menstrual Irregularity Plus Hyperandrogenism
- Obesity and the Polycystic Ovary Syndrome
- Medical comorbidities in patients with lichen planopilaris, a retrospective case–control study
- Metabolic syndrome and dermatological diseases: association and treatment
- Androgen excess and post-reproductive health
- A study on the clinical, biochemical and hormonal profile of polycystic ovary syndrome patients attending tertiary care hospital
- POLYCYSTIC OVARY SYNDROME: DIVERSE CLINICAL PRESENTATIONS ACROSS ADOLESCENCE, REPRODUCTIVE AGE, AND MENOPAUSE
- Exploring phytoandrogens: A review of their potential in health and medicine
- Anti-Müllerian Hormone and Ovarian Morphology in Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS): Toward More Precise Diagnosis and Phenotype Stratification
- 53289 Clinical and metabolic characteristics of male patients with early-onset androgenetic alopecia: A possible predisposition to metabolic syndrome
- EFFECTS OF HORMONAL THERAPY IN TRANSGENDERS
- Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence
- An Overview of Harmful Effects of Polycystic Ovary Syndrome
- Secreted Frizzled‐Related Protein 2 ( SFRP2 ) Induces Follistatin‐Like 1 ( FSTL1 ) to Regulate Dihydrotestosterone ( DHT )‐Induced Dermal Papilla Cell Mitochondrial Dysfunction and Senescence
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making
- Health consequences of anabolic steroids: a sexual-medicine perspective
- Unmasking the Overlooked Symptoms of PCOS: Navigating Ovulatory Dysfunction, Menstrual Disorders, and Acne
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Dermatologic Manifestations of Mitochondrial Dysfunction: A Review of the Literature
- Impact of Thyroid Dysfunction on Hair Disorders
- To evaluate the outcome of combined therapy of cyproterone acetate and ethinyl estradiol in PCOS
- Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial
- Chapter 6. Darwinian Health and Other Contradictions
- Nanocarriers for Improved Delivery of Angiotensin-(1-7)
- A cross-sectional, observational study of the clinico-epidemiological profile of female pattern hair loss in Western India and its association with metabolic syndrome
- 5α-Reductase inhibitors in androgenetic alopecia